Literature DB >> 12846579

Domain-specific interactions of talin with the membrane-proximal region of the integrin beta3 subunit.

Tobias S Ulmer1, David A Calderwood, Mark H Ginsberg, Iain D Campbell.   

Abstract

Activation (affinity regulation) of integrin adhesion receptors controls cell migration and extracellular matrix assembly. Talin connects integrins with actin filaments and influences integrin affinity by binding to the integrins' short cytoplasmic beta-tail. The principal beta-tail binding site in talin is a FERM domain, comprised of three subdomains (F1, F2, and F3). Previous studies of integrin alphaIIbbeta3 have shown that both F2 and F3 bind the beta3 tail, but only F3, or the F2-F3 domain pair, induces activation. Here, talin-induced perturbations of beta3 NMR resonances were examined to explore integrin activation mechanisms. F3 and F2-F3, but not F2, distinctly perturbed the membrane-proximal region of the beta3 tail. All domains also perturbed more distal regions of the beta3 tail that appear to form the major interaction surface, since the beta3(Y747A) mutation suppressed those effects. These results suggest that perturbation of the beta3 tail membrane-proximal region is associated with talin-mediated integrin activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12846579     DOI: 10.1021/bi034384s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  A membrane proximal region of the integrin alpha5 subunit is important for its interaction with nischarin.

Authors:  Suresh K Alahari; Hani Nasrallah
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

2.  Membrane-mediated structural transitions at the cytoplasmic face during integrin activation.

Authors:  Olga Vinogradova; Julia Vaynberg; Xiangming Kong; Thomas A Haas; Edward F Plow; Jun Qin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

3.  Subcellular localization of talin is regulated by inter-domain interactions.

Authors:  Asoka Banno; Benjamin T Goult; HoSup Lee; Neil Bate; David R Critchley; Mark H Ginsberg
Journal:  J Biol Chem       Date:  2012-02-18       Impact factor: 5.157

Review 4.  Structure and function of the platelet integrin alphaIIbbeta3.

Authors:  Joel S Bennett
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 5.  Integrin structures and conformational signaling.

Authors:  Bing-Hao Luo; Timothy A Springer
Journal:  Curr Opin Cell Biol       Date:  2006-08-14       Impact factor: 8.382

Review 6.  Structural basis of integrin regulation and signaling.

Authors:  Bing-Hao Luo; Christopher V Carman; Timothy A Springer
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

7.  Self-consistent residual dipolar coupling based model-free analysis for the robust determination of nanosecond to microsecond protein dynamics.

Authors:  Nils-Alexander Lakomek; Korvin F A Walter; Christophe Farès; Oliver F Lange; Bert L de Groot; Helmut Grubmüller; Rafael Brüschweiler; Axel Munk; Stefan Becker; Jens Meiler; Christian Griesinger
Journal:  J Biomol NMR       Date:  2008-06-04       Impact factor: 2.835

Review 8.  The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.

Authors:  Barry S Coller; Sanford J Shattil
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

9.  The talin rod IBS2 alpha-helix interacts with the beta3 integrin cytoplasmic tail membrane-proximal helix by establishing charge complementary salt bridges.

Authors:  Sophie Rodius; Olivier Chaloin; Michèle Moes; Elisabeth Schaffner-Reckinger; Isabelle Landrieu; Guy Lippens; Minghui Lin; Ji Zhang; Nelly Kieffer
Journal:  J Biol Chem       Date:  2008-06-23       Impact factor: 5.157

10.  The structure of an integrin/talin complex reveals the basis of inside-out signal transduction.

Authors:  Nicholas J Anthis; Kate L Wegener; Feng Ye; Chungho Kim; Benjamin T Goult; Edward D Lowe; Ioannis Vakonakis; Neil Bate; David R Critchley; Mark H Ginsberg; Iain D Campbell
Journal:  EMBO J       Date:  2009-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.